MTND1P5

Across TCGA pan-cancer cohorts, MTND1P5 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MTND1P5 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MTND1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P5 expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

BLCA, UCS, and LUAD are the cancer types where MTND1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.240	0.556	<.001	63	view →
UCS	DFS	Tertile	All	0.137	0.455	.026	54	view →
LUAD	OS	Tertile	III,IV	0.342	0.693	.028	42	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	27	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	18	view →
ESCA	OS	Median	III,IV	0.659	0.317	.002	17	view →
KICH	DFS	Tertile	All	0.121	0.867	.023	15	view →
LGG	DFS	Tertile	All	0.565	0.748	.015	15	view →
KIRP	OS	Tertile	All	0.788	0.956	.001	12	view →
GBM	DFS	Tertile	All	0.440	0.186	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MTND1P5–BLCA (DFS)

Open the BLCA breakdown →